Cargando…
Iron Supplements for Infants at Risk for Iron Deficiency
Professional societies have published recommendations for iron dosing of preterm neonates, but differences exist between guidelines. To help develop standardized guidelines, we performed a 10-year analysis of iron dosing in groups at risk for iron deficiency: IDM (infants of diabetic mothers), SGA (...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405879/ https://www.ncbi.nlm.nih.gov/pubmed/28491927 http://dx.doi.org/10.1177/2333794X17703836 |
_version_ | 1783231855298871296 |
---|---|
author | MacQueen, Brianna C. Baer, Vickie L. Scott, Danielle M. Ling, Con Yee O’Brien, Elizabeth A. Boyer, Caitlin Henry, Erick Fleming, Robert E. Christensen, Robert D. |
author_facet | MacQueen, Brianna C. Baer, Vickie L. Scott, Danielle M. Ling, Con Yee O’Brien, Elizabeth A. Boyer, Caitlin Henry, Erick Fleming, Robert E. Christensen, Robert D. |
author_sort | MacQueen, Brianna C. |
collection | PubMed |
description | Professional societies have published recommendations for iron dosing of preterm neonates, but differences exist between guidelines. To help develop standardized guidelines, we performed a 10-year analysis of iron dosing in groups at risk for iron deficiency: IDM (infants of diabetic mothers), SGA (small for gestational age), and VLBW premature neonates (very low birth weight, <1500 g). We analyzed iron dosing after red cell transfusions and erythropoiesis-stimulating agents (ESA). Of IDM, 11.8% received iron in the hospital; 9.8% of SGA and 27.1% of VLBW neonates received iron. Twenty percent of those who received iron had it started by day 14; 63% by 1 month. Supplemental iron was stopped after red cell transfusions in 73% of neonates receiving iron. An ESA was administered to 1677, of which 33% received iron within 3 days. This marked variation indicates that a consistent approach is needed, and using this report and a literature review, we standardized our iron-dosing guidelines. |
format | Online Article Text |
id | pubmed-5405879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-54058792017-05-10 Iron Supplements for Infants at Risk for Iron Deficiency MacQueen, Brianna C. Baer, Vickie L. Scott, Danielle M. Ling, Con Yee O’Brien, Elizabeth A. Boyer, Caitlin Henry, Erick Fleming, Robert E. Christensen, Robert D. Glob Pediatr Health Original Article Professional societies have published recommendations for iron dosing of preterm neonates, but differences exist between guidelines. To help develop standardized guidelines, we performed a 10-year analysis of iron dosing in groups at risk for iron deficiency: IDM (infants of diabetic mothers), SGA (small for gestational age), and VLBW premature neonates (very low birth weight, <1500 g). We analyzed iron dosing after red cell transfusions and erythropoiesis-stimulating agents (ESA). Of IDM, 11.8% received iron in the hospital; 9.8% of SGA and 27.1% of VLBW neonates received iron. Twenty percent of those who received iron had it started by day 14; 63% by 1 month. Supplemental iron was stopped after red cell transfusions in 73% of neonates receiving iron. An ESA was administered to 1677, of which 33% received iron within 3 days. This marked variation indicates that a consistent approach is needed, and using this report and a literature review, we standardized our iron-dosing guidelines. SAGE Publications 2017-04-25 /pmc/articles/PMC5405879/ /pubmed/28491927 http://dx.doi.org/10.1177/2333794X17703836 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article MacQueen, Brianna C. Baer, Vickie L. Scott, Danielle M. Ling, Con Yee O’Brien, Elizabeth A. Boyer, Caitlin Henry, Erick Fleming, Robert E. Christensen, Robert D. Iron Supplements for Infants at Risk for Iron Deficiency |
title | Iron Supplements for Infants at Risk for Iron Deficiency |
title_full | Iron Supplements for Infants at Risk for Iron Deficiency |
title_fullStr | Iron Supplements for Infants at Risk for Iron Deficiency |
title_full_unstemmed | Iron Supplements for Infants at Risk for Iron Deficiency |
title_short | Iron Supplements for Infants at Risk for Iron Deficiency |
title_sort | iron supplements for infants at risk for iron deficiency |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405879/ https://www.ncbi.nlm.nih.gov/pubmed/28491927 http://dx.doi.org/10.1177/2333794X17703836 |
work_keys_str_mv | AT macqueenbriannac ironsupplementsforinfantsatriskforirondeficiency AT baervickiel ironsupplementsforinfantsatriskforirondeficiency AT scottdaniellem ironsupplementsforinfantsatriskforirondeficiency AT lingconyee ironsupplementsforinfantsatriskforirondeficiency AT obrienelizabetha ironsupplementsforinfantsatriskforirondeficiency AT boyercaitlin ironsupplementsforinfantsatriskforirondeficiency AT henryerick ironsupplementsforinfantsatriskforirondeficiency AT flemingroberte ironsupplementsforinfantsatriskforirondeficiency AT christensenrobertd ironsupplementsforinfantsatriskforirondeficiency |